Skip to contentD
Dare Bioscience, Inc.
D
DAREDare Bioscience, Inc. Q1 2017 · 10-Q
Revenue$1.19M$1.19Mno prior Q1 2016 on file Net Income-$243.86K-$243.86KN/M vs Q1 2016 EPS Diluted-$0.27-$0.27N/M vs Q1 2016 Operating Income-$228,463— Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
Margins · derivedOperating margin-19.2%
Net margin-20.5%
ended Mar 31, 2017 · filed May 12, 2017 · 42 d after period end